proxyvotesnow.com

Home › Companies › TREACE MEDICAL CONCEPTS INC. › 2024-2025

TREACE MEDICAL CONCEPTS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and TREACE MEDICAL CONCEPTS INC.’s Form 8-K, filed 2025-05-21 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 6Reported items
  • 158Asset managers
  • 664Fund votes
  • 2025-05-20Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TREACE MEDICAL CONCEPTS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by TREACE MEDICAL CONCEPTS INC.

These tallies are TREACE MEDICAL CONCEPTS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-21 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TREACE MEDICAL CONCEPTS INC. — official shareholder meeting results, meeting held 2025-05-20
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Lawrence W. Hamilton 40,663,919---- 1,589,9839,208,628 Majority: yes
Elect Director: Deepti Jain 34,754,249---- 7,499,6539,208,628 Majority: yes
Proposal 2: Advisory Vote on Executive Compensation 39,922,5802,315,84815,474 --9,208,628 Majority: yes
Proposal 3: Ratification of Selection of Independent Registered Public Accounting Firm 51,392,62343,12726,780 --0 Majority: yes

Source: TREACE MEDICAL CONCEPTS INC., Form 8-K, filed with the SEC on 2025-05-21 — read the filing on EDGAR.

How asset managers voted at the TREACE MEDICAL CONCEPTS INC. 2024-2025 meeting

Each item below shows how the 158 asset managers that disclosed a TREACE MEDICAL CONCEPTS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of TREACE MEDICAL CONCEPTS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-20.

Combines 8 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 39,922,580AGAINST: 2,315,848

TREACE MEDICAL CONCEPTS INC.’s own tally for this item (“Proposal 2: Advisory Vote on Executive Compensation”): 39,922,580 for, 2,315,848 against, per its Form 8-K filed 2025-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 62,904,952 outstanding shares: 63% for, 4% against (67% of the company cast a for/against vote).

The 154 asset managers below cast 99% of the shares they voted on this item FOR (35,672,091 for, 493,261 against).

FOR 99%
FOR: 35,672,091 (98.6%)AGAINST: 493,261 (1.4%)ABSTAIN: 9,331 (0.0%)0: 165 (0.0%)
Largest asset managers voting on “APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at TREACE MEDICAL CONCEPTS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
CIBC Private Wealth Group LLC15,187,4640 00For
BlackRock3,612,04355,770 00For
Vanguard2,739,3650 00For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC2,466,6550 00For
JPMorgan1,392,1530 00For
Fidelity1,093,9710 00For
GEODE CAPITAL MANAGEMENT, LLC1,081,3910 00For
WILLIAM BLAIR FUNDS1,028,4800 00For
State Street920,6374,738 00For
Charles Schwab698,8560 00For
Northern Trust451,6072,316 00For
First Eagle Investment Management, LLC436,7870 00For
FIRST EAGLE FUNDS378,4910 00For
DRIEHAUS CAPITAL MANAGEMENT LLC369,9470 00For
BUFFALO FUNDS365,3930 00For
Nuveen246,6000 00For
TIAA245,0910 00For
Voya240,2140 00For
DE Shaw208,2590 00For
Lincoln Financial192,5260 00For
STIFEL NICOLAUS & CO INC \MO\186,5750 00For
Citadel185,7860 00For
Birchview Capital, LP164,3500 00For
MELLON INVESTMENTS Corp159,1610 00For
UBS154,9250 00For

Showing the 25 largest of 154 asset managers. See all 154 in the interactive database.

2. Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2025-05-20.

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 51,392,623AGAINST: 43,127

TREACE MEDICAL CONCEPTS INC.’s own tally for this item (“Proposal 3: Ratification of Selection of Independent Registered Public Accounting Firm”): 51,392,623 for, 43,127 against, per its Form 8-K filed 2025-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 62,904,952 outstanding shares: 82% for, 0.1% against (82% of the company cast a for/against vote).

The 48 asset managers below cast 100% of the shares they voted on this item FOR (9,272,757 for, 0 against).

FOR 99.8%
FOR: 9,272,757 (99.9%)ABSTAIN: 9,331 (0.1%)
Largest asset managers voting on “Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accountin” at TREACE MEDICAL CONCEPTS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard2,644,1070 00For
BlackRock2,066,8330 00For
WILLIAM BLAIR FUNDS1,028,4800 00For
Fidelity1,026,7470 00For
FIRST EAGLE FUNDS378,4910 00For
BUFFALO FUNDS365,3930 00For
Charles Schwab349,4270 00For
TIAA245,0910 00For
Lincoln Financial192,5260 00For
Equitable134,9150 00For
Voya120,1070 00For
Gabelli92,5000 00For
Brighthouse56,1310 9,3310For
Capitol Series Trust49,9800 00For
Grandeur Peak Global Trust45,6300 00For
SEI39,4720 00For
DRIEHAUS MUTUAL FUNDS39,0760 00For
NORTHERN LIGHTS FUND TRUST III36,6510 00For
Northern Trust36,2570 00For
Goldman Sachs33,5160 00For
Global X29,2170 00For
AIG/SunAmerica23,9020 00For
Nationwide22,8640 00For
RBB FUND, INC.20,7910 00For
Harbor ETF Trust19,0960 00For

Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.

3. Election of Directors: Deepti Jain

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-20.

Combines 4 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%WITHHELD 18%
FOR: 34,754,249WITHHELD: 7,499,653

TREACE MEDICAL CONCEPTS INC.’s own tally for this item (“Elect Director: Deepti Jain”): 34,754,249 for, 7,499,653 withheld, per its Form 8-K filed 2025-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 62,904,952 outstanding shares: 55% for, 12% withheld (67% of the company cast a for/withheld vote).

The 47 asset managers below cast 100% of the shares they voted on this item FOR (7,206,048 for, 0 against).

FOR 78%ABSTAIN 22%
FOR: 7,206,048 (78.4%)ABSTAIN: 1,983,540 (21.6%)
Largest asset managers voting on “Election of Directors: Deepti Jain” at TREACE MEDICAL CONCEPTS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard2,644,1070 00For
BlackRock2,066,8330 00For
WILLIAM BLAIR FUNDS00 1,028,4800Abstain
Fidelity1,026,7470 00For
FIRST EAGLE FUNDS00 378,4910Abstain
BUFFALO FUNDS365,3930 00For
Charles Schwab349,4270 00For
TIAA245,0910 00For
Lincoln Financial161,0730 31,4530For
Equitable76,7650 58,1500For
Voya00 120,1070Abstain
Brighthouse00 65,4620Abstain
Capitol Series Trust00 49,9800Abstain
Grandeur Peak Global Trust45,6300 00For
SEI39,4720 00For
DRIEHAUS MUTUAL FUNDS00 39,0760Abstain
NORTHERN LIGHTS FUND TRUST III36,6510 00For
Northern Trust00 36,2570Abstain
Goldman Sachs00 33,5160Abstain
Global X29,2170 00For
AIG/SunAmerica00 23,9020Abstain
Nationwide14,1450 8,7190For
RBB FUND, INC.00 20,7910Abstain
Harbor ETF Trust19,0960 00For
State Street19,0760 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

4. Election of Directors: Lawrence W. Hamilton

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-20.

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 40,663,919WITHHELD: 1,589,983

TREACE MEDICAL CONCEPTS INC.’s own tally for this item (“Elect Director: Lawrence W. Hamilton”): 40,663,919 for, 1,589,983 withheld, per its Form 8-K filed 2025-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 62,904,952 outstanding shares: 65% for, 3% withheld (67% of the company cast a for/withheld vote).

The 47 asset managers below cast 100% of the shares they voted on this item FOR (9,129,090 for, 0 against).

FOR 99.3%
FOR: 9,129,090 (99.3%)ABSTAIN: 60,498 (0.7%)
Largest asset managers voting on “Election of Directors: Lawrence W. Hamilton” at TREACE MEDICAL CONCEPTS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard2,644,1070 00For
BlackRock2,066,8330 00For
WILLIAM BLAIR FUNDS1,028,4800 00For
Fidelity1,026,7470 00For
FIRST EAGLE FUNDS378,4910 00For
BUFFALO FUNDS365,3930 00For
Charles Schwab349,4270 00For
TIAA245,0910 00For
Lincoln Financial192,5260 00For
Equitable134,9150 00For
Voya120,1070 00For
Brighthouse56,1310 9,3310For
Capitol Series Trust49,9800 00For
Grandeur Peak Global Trust45,6300 00For
SEI39,4720 00For
DRIEHAUS MUTUAL FUNDS39,0760 00For
NORTHERN LIGHTS FUND TRUST III00 36,6510Abstain
Northern Trust36,2570 00For
Goldman Sachs33,5160 00For
Global X29,2170 00For
AIG/SunAmerica23,9020 00For
Nationwide22,8640 00For
RBB FUND, INC.20,7910 00For
Harbor ETF Trust19,0960 00For
State Street19,0760 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

5. Approval, on an advisory, non-binding basis, of the H of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-20.

95% Majority: yes · of votes cast

FOR 95%
FOR: 39,922,580AGAINST: 2,315,848

TREACE MEDICAL CONCEPTS INC.’s own tally for this item (“Proposal 2: Advisory Vote on Executive Compensation”): 39,922,580 for, 2,315,848 against, per its Form 8-K filed 2025-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 62,904,952 outstanding shares: 63% for, 4% against (67% of the company cast a for/against vote).

The 2 asset managers below cast 58% of the shares they voted on this item FOR (49,980 for, 36,651 against).

FOR 58%AGAINST 42%
FOR: 49,980 (57.7%)AGAINST: 36,651 (42.3%)
Largest asset managers voting on “Approval, on an advisory, non-binding basis, of the H of the Company's named executive officers.” at TREACE MEDICAL CONCEPTS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Capitol Series Trust49,9800 00For
NORTHERN LIGHTS FUND TRUST III036,651 00Against

6. Approval, on an advisory, non- binding basis, of the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-05-21 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%
FOR: 44,766,561AGAINST: 4,009,999

TREACE MEDICAL CONCEPTS INC.’s own tally for this item (“Proposal 2: Advisory Vote on Executive Compensation”): 44,766,561 for, 4,009,999 against, per its Form 8-K filed 2024-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 62,904,952 outstanding shares: 71% for, 6% against (78% of the company cast a for/against vote).

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 15 against).

AGAINST 100%
AGAINST: 15 (100.0%)
Largest asset managers voting on “Approval, on an advisory, non- binding basis, of the compensation of the Company's named executive officers.” at TREACE MEDICAL CONCEPTS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
COLDSTREAM CAPITAL MANAGEMENT INC015 00Against
Echo45 Advisors LLC00 00--

Largest TREACE MEDICAL CONCEPTS INC. shareholders voting in 2024-2025

Ranked by the number of TREACE MEDICAL CONCEPTS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 62,904,952 shares outstanding at the time of that meeting.

Top TREACE MEDICAL CONCEPTS INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1CIBC Private Wealth Group LLC 24.14%
2BlackRock 5.83%
3Vanguard 4.35%
4WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 3.92%
5JPMorgan 2.21%
6Fidelity 1.74%
7GEODE CAPITAL MANAGEMENT, LLC 1.72%
8WILLIAM BLAIR FUNDS 1.63%
9State Street 1.47%
10Charles Schwab 1.11%

Reported TREACE MEDICAL CONCEPTS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

TREACE MEDICAL CONCEPTS INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
Neil Gagnon 9.76% 13G
BlackRock 6.17% 13F
BANK OF AMERICA CORP /DE/ 5.62% 13G
Vanguard Group 4.30% 13F
JPMorgan Chase 2.94% 13F
Morgan Stanley 2.44% 13F
Geode Capital 1.73% 13F
State Street 1.56% 13F
D.E. Shaw 1.46% 13F
Northern Trust 0.78% 13F

Percentages above are of 62,904,952 shares outstanding, as reported by TREACE MEDICAL CONCEPTS INC. on its Form 10-Q dated 2025-04-30 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TREACE MEDICAL CONCEPTS INC.’s 10-Q dated 2025-04-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At TREACE MEDICAL CONCEPTS INC.'s shareholder meeting held 2025-05-20, in the 2024-2025 proxy season, 158 asset managers reported how they voted in their SEC Form N-PX filings, covering 664 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED… — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: TREACE MEDICAL CONCEPTS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-21.

TREACE MEDICAL CONCEPTS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.